Citation:Rubenstein JH, Vakil N, Inadomi JM 2005

Citation

Rubenstein JH, Vakil N, Inadomi JM. The cost-effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma. Aliment Pharmacol Ther 2005 Jul 15;22(2):135-46 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/16011672.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Rubenstein JH, Vakil N, Inadomi JM 2005	Are there useful biomarkers to detect and improve the diagnosis of neoplasia in patients with or without BO?	Melissa Thomas	pending

Compare quality appraisals for each clinical question

• Are there useful biomarkers to detect and improve the diagnosis of neoplasia in patients with or without BO? (compare critical appraisals)

Cited by

1. Is surveillance cost-effective for follow-up of patients with BO?